MARY MOREY: Open Payments
NPI 1972500874 · SOUTH BEND, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,412 in 126 payments from 23 companies in 2025. Trend: 2023 $1,873 · 2024 $2,499 · 2025 $2,412
Food & beverage: $2,412
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 29 | $367 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 13 | $267 |
| Janssen Biotech, Inc. | 13 | $238 |
| Takeda Pharmaceuticals U.S.A., Inc. | 11 | $217 |
| Ardelyx, Inc. | 10 | $166 |
| Gilead Sciences, Inc. | 10 | $155 |
| Madrigal Pharmaceuticals | 8 | $153 |
| Insulet Corporation | 1 | $143 |
| GENZYME CORPORATION | 6 | $131 |
| Organon LLC | 4 | $92 |
Products named: RINVOQ, XIFAXAN, TREMFYA, DUPIXENT, IBSRELA, REZDIFFRA, OMNIPOD, EOHILIA.
Industry payments across IN — which companies pay providers there.
